β-blockers: a novel class of antitumor agents

β-adrenergic signaling modulates key signaling pathways that are important for tumor-promoting processes, and numerous mechanisms of action have been elucidated. Preclinical studies have demonstrated that β-adrenergic antagonists, or β-blockers, can block multiple fundamental biologic processes unde...

Descripción completa

Detalles Bibliográficos
Autores principales: Ji, Yi, Chen, Siyuan, Xiao, Xianmin, Zheng, Shan, Li, Kai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3513911/
https://www.ncbi.nlm.nih.gov/pubmed/23226026
http://dx.doi.org/10.2147/OTT.S38403

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3513911/
https://www.ncbi.nlm.nih.gov/pubmed/23226026
http://dx.doi.org/10.2147/OTT.S38403

Ejemplares similares